Dätwyler Holding AG (LON:0QNJ)
London · Delayed Price · Currency is GBP · Price in CHF | Market Cap | 1.98B -12.5% |
| Revenue (ttm) | 1.04B +2.0% |
| Net Income | 76.68M +170.4% |
| EPS | 4.51 +170.2% |
| Shares Out | n/a |
| PE Ratio | 25.78 |
| Forward PE | 21.02 |
| Dividend | 3.03 (2.61%) |
| Ex-Dividend Date | Mar 19, 2026 |
| Volume | 223 |
| Open | 127.30 |
| Previous Close | 127.30 |
| Day's Range | 126.80 - 127.90 |
| 52-Week Range | 123.20 - 172.00 |
| Beta | 1.10 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 11, 2027 |
About Dätwyler Holding AG
Dätwyler Holding AG engages in the production and sale of elastomer components for healthcare, automotive, industries, and food and beverage industries in Switzerland, rest of Europe, North and South America, Asia, and internationally. It operates in two divisions, Healthcare and Industrial. The Healthcare division offers rubber components for prefilled syringes, pens, and injection systems; components and closures for injectable drugs in vials; and rubber components for blood collection systems, IV administration sets, disposable syringes, dia... [Read more]
Financial Performance
In 2025, Dätwyler Holding AG's revenue was 1.10 billion, a decrease of -0.65% compared to the previous year's 1.11 billion. Earnings were 80.80 million, an increase of 159.81%.
Financial numbers in CHF Financial StatementsNews
Dätwyler Holding AG Earnings Call Transcript: H1 2026
Net revenue grew 3.5% to CHF 582.7 million in H1 2026, with organic growth at 4.6% and strong performance in Healthcare. EBIT margin improved to 13%, and the Capsul'in acquisition is integrating well. Outlook remains positive, with midterm targets reaffirmed.
Dätwyler Holding AG Quarterly report: H1 2026
Dätwyler Holding AG has published its H1 2026 quarterly earnings report on July 23, 2026.
Dätwyler Holding AG Slides: H1 2026
Dätwyler Holding AG has posted slides in relation to its H1 2026 quarterly earnings report, which was published on July 23, 2026.
Dätwyler Holding AG Earnings Call Transcript: H2 2025
Net revenue reached CHF 1.1 billion in 2025, with Healthcare driving margin and earnings growth. EBIT margin rose to 12.4%, and leverage improved to 1.8x. Outlook for 2026 focuses on structural growth in Healthcare and continued operational improvements.
Dätwyler Holding AG Quarterly report: H2 2025
Dätwyler Holding AG has published its H2 2025 quarterly earnings report on February 12, 2026.
Dätwyler Holding AG Annual report: H2 2025
Dätwyler Holding AG has published its H2 2025 annual report on February 12, 2026.
Dätwyler Holding AG Slides: H2 2025
Dätwyler Holding AG has posted slides in relation to its H2 2025 quarterly earnings report, which was published on February 12, 2026.
Dätwyler Holding AG Transcript: CMD 2025
Management is executing a transformation program to drive growth in high-value, system-critical components, focusing on healthcare and industrial niches with strong innovation and operational leverage. Midterm targets include higher single-digit revenue growth and a 17%+ EBIT margin, supported by portfolio optimization and disciplined capital allocation.
Dätwyler Holding AG Slides: FY 2025
Dätwyler Holding AG has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 19, 2025.